Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

A team of scientists in California has tweaked the hallucinogenic drug LSD to make it usable to treat schizophrenia and other neuropsychiatric and neurodegenerative diseases.According to the ...

Another reason for choosing a particular modality is that it is a team’s specialty. Strategic choices can be less about determining which modality best fits a potential target than about choosing a ...

University of California, Davis, researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that ...

LSD has always been a source of fascination for Olson because of its outstanding ability to form and strengthen neural ...

Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic's therapeutic power with reduced hallucinogenic potential.